Amongst the genes located on other chromosomes, insulin-like growth factor-2 mRNA-binding protein-1 (IGF2BP1) located on chromosome 17q21.32 is highly expressed in patients with MM and concurrent + 1q alterations; high expression of IGF2BP1 predicts a poor prognosis [33]. This evidence concerns the gene IGF2BP1 and Miyoshi myopathy.